Clinical trial
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
NCT00643994
Study timeline
Study start (unknown)2007-12-01Date precision: month
Registry last updated2023-05-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Prostatic Cancerunresolved
Prostate Neoplasmsunresolved
Prostatic Neoplasmsunresolved
Cancer of the Prostateunresolved
Interventions
CyberKnife Stereotactic RadiosurgeryRADIATION
Sponsors & collaborators
Accuray Incorporatedlead sponsor
Mapped research locations
BaltimoreMaryland, United States2St LouisMissouri, United States2VancouverWashington, United States2BostonMassachusetts, United States1SeattleWashington, United States1Washington D.C.District of Columbia, United States1PhoenixArizona, United States1Ann ArborMichigan, United States1La JollaCalifornia, United States1LexingtonKentucky, United States1SyracuseNew York, United States1Newport BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00643994 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.